Jazz Pharmaceuticals plc — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2022-06-02

Reporting Person: Carr Patricia (SVP, Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-02	Ordinary Shares	S	131	$150.26	Disposed	6234	Direct

Footnotes

F1: Unchanged; the 131 ordinary shares sold were acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2022.